当前位置:首页 - 行情中心 - 睿智医药(300149) - 财务分析

睿智医药

(300149)

  

流通市值:50.85亿  总市值:50.94亿
流通股本:4.97亿   总股本:4.98亿

睿智医药(300149)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.07亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益124441.35万元,未分配利润-67392.96万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产198706.32万元,负债74264.97万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入261,261,312.24970,204,758.8718,525,731.65465,164,579.93
营业总成本260,328,377.291,031,638,143.67774,216,447.7525,102,424.42
营业利润9,366,855.16-216,837,181.52-66,557,761.02-69,672,275.36
利润总额9,323,669.29-231,643,863-67,038,704.04-70,057,447.06
净利润6,623,398.35-226,512,315.17-61,782,349.49-62,980,202.1
其他综合收益-272,754.983,689,524.72-9,433,940.61-1,144,800.81
综合收益总额6,350,643.37-222,822,790.45-71,216,290.1-64,125,002.91
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计645,941,574.54644,069,184.3623,951,592615,056,179.17
非流动资产合计1,341,121,583.271,351,738,784.961,532,696,9361,639,791,860.74
资产总计1,987,063,157.811,995,807,969.262,156,648,5282,254,848,039.91
流动负债合计333,746,540.5346,697,976.55347,226,879.58360,464,093.76
非流动负债合计408,903,156.39411,047,175.16419,752,330.52497,623,341.06
负债合计742,649,696.89757,745,151.71766,979,210.1858,087,434.82
归属于母公司股东权益合计1,220,230,623.221,213,861,296.551,365,545,650.891,372,595,306.31
股东权益合计1,244,413,460.921,238,062,817.551,389,669,317.91,396,760,605.09
负债和股东权益合计1,987,063,157.811,995,807,969.262,156,648,5282,254,848,039.91
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计257,944,775.861,073,629,719.51788,197,815.19533,647,375.72
经营活动现金流出小计247,886,029.1905,422,428.43675,652,696.34462,584,127.61
经营活动产生的现金流量净额10,058,746.76168,207,291.08112,545,118.8571,063,248.11
投资活动现金流入小计632,530.327,221,215.115,806,006.035,644,307.31
投资活动现金流出小计11,982,154.4274,889,662.0764,233,346.9753,622,037.96
投资活动产生的现金流量净额-11,349,624.1-67,668,446.96-58,427,340.94-47,977,730.65
筹资活动现金流入小计-58,450,00028,450,00018,450,000
筹资活动现金流出小计19,430,180.29144,886,348.34109,664,255.9880,464,868.02
筹资活动产生的现金流量净额-19,430,180.29-86,436,348.34-81,214,255.98-62,014,868.02
汇率变动对现金及现金等价物的影响314,695.077,117,000.81-1,598,568.527,911,685.01
现金及现金等价物净增加额-20,406,362.5621,219,496.59-28,695,046.59-31,017,665.55
期末现金及现金等价物余额343,000,036.81363,448,871.8313,534,328.62311,211,709.66
TOP↑